Journal
The oncologist
Publication Date
8-5-2022
Volume
27
Issue
8
First Page
623
Last Page
e624
Document Type
Open Access Publication
DOI
10.1093/oncolo/oyac004
Rights and Permissions
Missak Haigentz, Page Moore, Milan Bimali, Timothy Cooley, Joseph Sparano, Michelle Rudek, Lee Ratner, David Henry, Juan Ramos, John Deeken, Paul Rubinstein, Elizabeth Chiao, Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study, The Oncologist, Volume 27, Issue 8, August 2022, Pages 623–e624, https://doi.org/10.1093/oncolo/oyac004. https://academic.oup.com/oncolo/article/27/8/623/6569249?login=true. © The Author(s) 2022. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
Recommended Citation
Haigentz, Missak; Moore, Page; Bimali, Milan; Cooley, Timothy; Sparano, Joseph; Rudek, Michelle; Ratner, Lee; Henry, David; Ramos, Juan; Deeken, John; Rubinstein, Paul; and Chiao, Elizabeth, "Safety and tolerability of carboplatin and paclitaxel in cancer patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) study." The oncologist. 27, 8. 623 - e624. (2022).
https://digitalcommons.wustl.edu/oa_4/4676
Department
ICTS (Institute of Clinical and Translational Sciences)
